TWi Biotechnology Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-202.37	-164.81	-170.68	-76.18	-15.3
Depreciation & Amortization	35.32	9.7	9.74	10.33	11.08
Other Amortization	-	-	0	0.02	0.02
Stock-Based Compensation	-	-0.88	5.5	3.08	-
Other Operating Activities	-155.14	-	-0.01	-	-
Change in Accounts Receivable	-0.28	-0.45	0.13	3.56	-3.41
Change in Inventory	-	-	-	-	2.34
Change in Unearned Revenue	-	-	-	-	-30.07
Change in Other Net Operating Assets	35.48	1.02	21.1	-1.06	0.87
Operating Cash Flow	-286.99	-155.41	-134.22	-60.24	-34.46
Capital Expenditures	-0.41	-0.31	-	-	-0.23
Sale (Purchase) of Intangibles	-5.46	-	-	-	-30
Investment in Securities	48.8	123.05	-171.85	34.3	191.9
Other Investing Activities	-0.03	-	-	-	-0.03
Investing Cash Flow	42.9	122.75	-171.85	34.3	161.64
Short-Term Debt Issued	-	10	-	-	7.6
Total Debt Issued	-	10	-	-	7.6
Short-Term Debt Repaid	-10	-	-	-	-7.6
Long-Term Debt Repaid	-2.66	-2.37	-2.5	-2.5	-2.46
Total Debt Repaid	-12.66	-2.37	-2.5	-2.5	-10.06
Net Debt Issued (Repaid)	-12.66	7.63	-2.5	-2.5	-2.46
Issuance of Common Stock	180	-	300	-	-
Financing Cash Flow	167.34	7.63	297.5	-2.5	-2.46
Net Cash Flow	-76.75	-25.04	-8.57	-28.44	124.72
Free Cash Flow	-287.4	-155.72	-134.22	-60.24	-34.69
Free Cash Flow Margin	-	-	-	-	-52.24%
Free Cash Flow Per Share	-2.61	-1.78	-1.83	-0.89	-0.51
Cash Interest Paid	-	0.16	0.09	0.05	0.09
Levered Free Cash Flow	-124	-134.11	-68.48	-40.34	-88.91
Unlevered Free Cash Flow	-123.89	-134.02	-68.43	-40.31	-88.85
Change in Working Capital	35.21	0.57	21.24	2.5	-30.26